Hepatitis C Board decisions

The Veteran's hepatitis C was found to have manifested in service and is attributable to service, granting service connection for the condition.

The Board has determined that the Veteran's current hepatitis C was not incurred during service and is more likely related to post-service drug use, specifically intravenous drug use and cocaine through the nasal passages. As a result, the claim for service connection for the residuals of hepatitis C is denied.

The Board has granted service connection for diabetes mellitus on a presumptive basis due to exposure to herbicide agents, but denied service connection for hepatitis C.

The Veteran's claims for service connection were denied. The Board found that the evidence did not meet the criteria for a 70% rating for PTSD and dismissed the claim for memory loss as it was part of the service-connected PTSD. The other claims, including those related to hepatitis C and left knee disorder, were also denied.

The Board has determined that the Veteran's current diagnosis of hepatitis C is not related to his active service and therefore denied his claim for service connection.

The Veteran withdrew his service connection claims for stomach ulcers and hepatitis C during the August 2017 hearing.

The Veteran's cause of death was due to metastatic hepatocellular carcinoma and hepatitis C cirrhosis, which the Board found were not related to his military service.

The Board has granted service connection for the Veteran's urological condition (iatrogenic hypospadias) and denied service connection for Hepatitis C and hypertension. The urological condition is considered a direct result of in-service medical procedures, while there is no evidence to support service connection for Hepatitis C or hypertension.

The Veteran's hepatitis C was manifested by fatigue, mild stomach pain, and a slight decrease in appetite prior to February 5, 2010. The criteria for a higher rating were not met.

The Veteran's dermatophytosis, which covers approximately 20-40 percent of his body during flare-ups, warrants a rating in excess of 10 percent.,VA medical evidence does not support service connection for hepatitis C.

The Veteran's hepatitis C is found to have had its onset during his period of active service, and the Board grants service connection for this condition.

The Board has granted the Veteran's claims of service connection for PTSD, lumbar and cervical spine disabilities, and hepatitis C. The lumbar and cervical spine disabilities are considered to be directly related to service based on the evidence provided.

The Board has remanded the case due to the need for additional development, including obtaining Social Security Administration records and updated VA medical records.

The Board has determined that the Veteran's hepatitis C disability is not related to his service and denied his claim for service connection.

The Veteran's appeal is being remanded for additional development to obtain his SSA records and provide addendum opinions regarding the etiology of his cardiac disorder, hypertension, and sleep apnea.

The Veteran's hepatitis C with ascites is related to his military service, and the Board has granted service connection for this condition.

The Veteran's claims for service connection have been denied. The Board finds that the evidence does not support a finding of current diagnoses or a link between any claimed conditions and active military service.,No new effective date has been granted as no earlier effective date claim was filed.

The Board has remanded the case for additional development due to deficiencies in the VA's duty to assist and potential errors in a previous decision.

The Board has ordered the VA to obtain the Veteran's service treatment records and any outstanding VA treatment records. They are also asked to provide a medical opinion regarding whether hepatitis C, which was diagnosed in the early 1990s, is related to active duty or contributed to the cause of death.

The Veteran's service-connected hepatitis C is currently rated at 60 percent, effective January 6, 2017. The rating reflects daily fatigue and nausea with six weeks or more of incapacitating episodes during the past year.